Tear Sheet: CohBar Inc. ($CWBR)

by DrKSSMDPhD | October 6, 2017 2:00 pm

This is premium content. To view this article (and to have full access to the rest of our articles), sign up. Already a member? Log in.

Source URL: https://sgumdev.stockgumshoe.com/2017/10/tear-sheet-cohbar-industries-cwbr/


2.7K Comments
Inline Feedbacks
View all comments

Notice: Undefined variable: karmaOutput in /home/sgumdev/public_html/wp-content/themes/sgum_2016/functions.php on line 3288
belgianchocolate
belgianchocolate
4 years ago

$NOTICKER

Messing up the rhythm of DNA replication may become another addition to the arsenal of cancer therapies in the future according to this Danish study:

http://healthsciences.ku.dk/news/2017/11/researchers-exploit-rhythm-of-dna-replication-to-kill-cancer-cells/

Talking about rhythm, here is to all of you Gummies, wishing each &everyone of you a great day:

https://www.youtube.com/watch?v=N141waS8uq4

Wim.

Add a Topic
3397
πŸ‘ 129
Leo
Leo
4 years ago

For those of you on this thread who can’t get the Torrey Hills thread. I got to it by going to the “recent comments”on the upper right of this thread screen and clicking on the “more” of the Torrey Hills comment. Good luck and the best to all the Gummies.

πŸ‘ 166
diplacus
diplacus
4 years ago

Current portfolio, with percentage of total holdings, in order of decreasing size: APTO 6.8%, PIRS 6.2%, CLRB 6.1%, HALO 6.0%, PTGX 5.7%, AUPH 5.2%, CWBR 5.2%, CAPR 5.1%, STML 5.0%, SRRA 4.5%, ESPR 3.9%, BLPH 3.8%, ARTH 3.6%, SNDX 3.6%, TRIL 3.5%, ONCS 3.1%, AKBA 3.0%, REPH 2.8%, MDGL 2.3%, DERM 2.0%, SCYX 2.0%, AXSM 1.9%, AAVXF 1.0%, β€œdry powder” 7.7%.

Changes made since last posting: Sold: AKTX, AXSM (decreased), BIOC, CAPR (decreased), RGLS, ZFGN. Bought: AAVXF, CLRB (increased), CWBR, DERM, MDGL, ONCS, PIRS (increased).

I invest only in the biotech sector and I am happy to enjoy the ups and downs of this extremely volatile part of the economy because I am a long-term investor, and only because of Dr. KSS. I would not be investing in any of these stocks without him and I am extremely grateful for the expertise he provides. Thank you, Dr. KSS. Thank you, Cleveland, for all of the work you do to provide financial analyses of these companies.

Add a Topic
1340
Add a Topic
3932
Add a Topic
3932
πŸ‘ 126
πŸ‘ 47658
Mitch
Mitch
4 years ago
Reply to  DrKSSMDPhD

Doc, not to beat the $HALO horse to death, but have your opinions on timing changed since the Q3 conference call? Prior to that, you were thinking potentially Q2 2018, but that was when the ORR data readout was supposed to take place in 2017. Now that it has been pushed to 2018 (2H i think?), do you feel that all the interested players are more likely to wait now until late 2018 or possibly even 2019 to pull the trigger? Thanks Doc!

πŸ‘ 16
πŸ‘ 47658
duck814
duck814
4 years ago
Reply to  DrKSSMDPhD

$HALO long.

Implied volatility in HALO options is surging today. I’m not an options trader but the article indicates that is is a harbinger of a large expected move in the underlying stock.
https://finance.yahoo.com/news/implied-volatility-surging-halozyme-therapeutics-134901450.html

Add a Topic
570
Add a Topic
570
Add a Topic
5971
πŸ‘ 29
πŸ‘ 47658
hennot
hennot
4 years ago
Reply to  duck814

$Halo long calls

Hi Duck,

Thanks for posting the article. Reading it there isn’t a lot of information in it. Seems like one of those robo-written pieces:”That is because the Dec 15th 2017 $8.00 Put had some of the highest implied volatility of all equity options today.”

That is completely logical because the farther out of the money you go the more expected value is in an option and as a consequence a higher implied volatility. The last time this option traded though was on September 29th. And there is the same bid/ask spread for the put dec $ 16.00.

Best regards, Henno

Add a Topic
4733
πŸ‘ 44
jabberwocky
jabberwocky
4 years ago
Reply to  diplacus

$noticker

Fantastic portfolio and weighting.

πŸ‘ 801
Jeffrey M
Jeffrey M
4 years ago

I’ll show you mine since you showed me yours (!); this is the Gummy portion of my portfolio

$ESPR: 16%
$APTO: 13%
$HALO: 12%
$CTEQF: 11% (not bio but a gummy name; thank you HN!)
$MRTX: 8%
$ARTH: 7%
$CWBR: 5%
$ONCS: 5%
$CAPR: 5%
$CLRB: 5%
Cash: 5% (will likely re-enter $TRIL)
Balance: 3 names that my employer won’t let me sell πŸ™

Please note that $ESPR, $APTO and $CTEQF are the sizes that they are because of unrealized gains; I still believe in each of them. I recently sold out of $AUPH and reduced $ARTH for names with nearer term catalysts. Will likely re-enter/add to each during 2018. Thank you Dr. KSS for all that you do; my wife’s IRA thanks you!

Add a Topic
3932
πŸ‘ 766
meadowbrookmanor
meadowbrookmanor
4 years ago

$ONOV small position
Has anyone had any problems trading this stock? I have a small amount in an account at Zacks and thought I would take advantage of this mornings pop (from ~$.07 to $.11) and close it out to replenish my “dry powder”, but received an error message when attempting to do so. Called Zacks after a 30 minute wait on hold while they tried to figure out why, I was told I am not allowed to sell this via Limit order. Since Zacks told me the going market rate was $.07-something, I decided to continue holding for now. Zacks says this is a new MM rule and they can do nothing for me. I bought this small position via limit order through them, and am dismayed at the prospect of selling it via a market order.

Can anyone shed any light on this? My apologies if this is a stupid question!
(edited to reflect correct brokerage)

Add a Topic
5971
Add a Topic
665
Add a Topic
665
πŸ‘ 98
Opposeablethumb
4 years ago

$ONOV sp – I can see that the bid is 7 cents and the ask is 11 cents. I am able to put in a limit order with Ameritrade. Of course it will not execute unless I lower to 7 cents. I think you have received a bad explanation is all, there are no current buyers at 11 cents, you could put a limit order in at 6 cents and watch it get executed. It is a bizarre world where a market maker can force you to sell at market.

πŸ‘ 1313
meadowbrookmanor
meadowbrookmanor
4 years ago

$ONOV sp
Agreed – I’ve never heard of such a thing… but then I’ve not often traded in such stocks. I was explicitly told I could not place a limit order at ANY price. Period – that it was out of the broker’s hands. Do you think this is erroneous?

πŸ‘ 98
swgoombah
swgoombah
4 years ago

$ONOV – NP – That does seem odd. Etrade will only let me place limit orders on OTC stocks, even $CWBR. If I try and do a market order I get this message: Non-equity, bulletin board, OTC, pink sheet and other specific securities are not eligible for the price type you have specified.

πŸ‘ 410
Opposeablethumb
4 years ago

If it is the market maker then that should apply to all brokers methinks. I would leave Zacks over such a practice myself.

Add a Topic
665
πŸ‘ 1313
meadowbrookmanor
meadowbrookmanor
4 years ago

$ONOV
Clearly, if Zacks cannot make limit orders of OTC stocks, they are in my rear view mirror. They indicated quite clearly though that the restriction stemmed from MMs, NOT themselves and that it was a new rule, enacted about a month ago. I don’t see how this could be kosher, requiring someone to sell a highly volatile stock via market order when the same position was purchased via a limit. I’m a bit upset and relieved this is only a smallish position.
Again, thank you for your thoughts!

Add a Topic
665
Add a Topic
5971
πŸ‘ 98
meadowbrookmanor
meadowbrookmanor
4 years ago

$ONOV $Zacktrades trade problem update:
I received an email from Zack’s apologizing for the confusion. As expected, limit orders are completely ok with the proviso that they must remain within the spread for orders less than 10,000 shares. It was not clear if it was ONOV in particular or all OTC stocks. I was able to place a suitable limit order, which the system would not allow yesterday, so they fixed whatever glitch was behind it.
Thank you all for your thoughts and comments – much appreciated!

Add a Topic
665
πŸ‘ 98
SoGiAm
4 years ago

$ONOV, Hi MeadowBrookManor, We have moved on to the following thread: : https://www.sgumdev.stockgumshoe.com/2017/11/notes-from-torrey-hills-capital-emerging-growth-conference-13-15-november-2017-san-diego-ca/ “Notes from Torrey Hills Capital Emerging Growth Conference, 13-15 November 2017, San Diego, CA” Best2YOU! Always able to locate most recent #ZKSS thread by going to https://www.sgumdev.stockgumshoe.com/author/dr-kss-md-phd/
or by clicking on #ZKSS image in the long hallway to the left of any of HIS posts. Same goes for anyone who has ever created a discussion on stockgumshoe. Click on the image to see his profile page and last thread and last 20 posts. Best2ALL!

Add a Topic
172
πŸ‘ 11466
meadowbrookmanor
meadowbrookmanor
4 years ago
Reply to  SoGiAm

Thank you SoGiAm – much obliged!

πŸ‘ 98
alternativerealitystar
alternativerealitystar
4 years ago

$CAPR

Another blogger’s perspective on Capricor’s Hope-DMD trial’s 12 month results.

http://alanhobbes.blogspot.sg/2017/11/capricors-12-month-results-brings-hope.html

Add a Topic
5912
πŸ‘ 257
SoGiAm
4 years ago

#Failures – Most of these causes are particularly relevant to #biotech #equities, as well: comment image
https://twitter.com/calestous/status/934013920863453184

πŸ‘ 11466
Road Dog
Road Dog
4 years ago

$CWBR Long… Juvenescence Video

https://youtu.be/vzH3HGk1rIo

Add a Topic
5935
πŸ‘ 102
pvbemmelen
4 years ago

$CWBR

Does anyone know if they are still expecting to uplist this year, or is this more likely a first quarter 2018 event?

πŸ‘ 47658
hedgeclipper
hedgeclipper
4 years ago
Reply to  DrKSSMDPhD

Not to disagree Dr. but I think there is still time for the uplisting to occur this year.

πŸ‘ 16
niizajim
4 years ago
Reply to  hedgeclipper

$CLBR Hopefully the uplisting WILL be this year, but I guess it’s a hard call. Fezziwig on Twitter keeps saying it will be this year. Either way, we’re good. Looking forward to great things from this company next year! Thanks to Doc for the recommendation.

πŸ‘ 974
SoGiAm
4 years ago
Reply to  niizajim

$CWBR ow – NiizaJim πŸ˜‰ Long #ZKSS &
#Gr8Gummune! #Best2ALL!

πŸ‘ 11466
telcomonster
telcomonster
4 years ago
πŸ‘ 169
hedgeclipper
hedgeclipper
4 years ago
Reply to  telcomonster

CohBar to list on Nasdaq this Friday!
CohBar Announces Approval for Listing on the NASDAQ Capital Market
NASDAQ Trading to Begin on December 15, 2017 Under Existing Ticker Symbol CWBR
MENLO PARK, Calif., Dec. 13, 2017 (GLOBE NEWSWIRE) — CohBar, Inc. (OTCQX:CWBR) (TSXV:COB.U), an innovative biotechnology company focused on developing mitochondria based therapeutics (MBTs) to treat age-related diseases, today announced that The NASDAQ Stock Market LLC has approved the Company’s application to list its common stock on the NASDAQ Capital Market (NASDAQ).
CohBar’s common stock is expected to commence trading on the NASDAQ Capital Market at the opening of trading on December 15, 2017 under the ticker symbol CWBR. The Company’s common stock will continue to trade on the OTCQX until market close on December 14, 2017 under the ticker symbol CWBR. In addition to trading on the NASDAQ Capital Market, the Company’s common stock will also continue to trade on the TSX Venture Exchange under the ticker symbol COB.U.
β€œListing on NASDAQ represents a major milestone for our Company and its shareholders, reflecting the significant progress our team has made in preparing CB4211 for clinical trials, and in securing our leadership position in the development of MBTs, a new class of therapeutics with the potential to treat a wide range of age-related diseases,” said Simon Allen, CohBar CEO. β€œWe believe that our NASDAQ listing will significantly enhance our visibility in the marketplace, attract institutional investors, and ultimately help us to realize greater value for our shareholders as we expand our pipeline of novel therapeutics that harness the power of the mitochondria and its encoded peptides.”

Add a Topic
5916
Add a Topic
5971
Add a Topic
5971
πŸ‘ 16
hedgeclipper
hedgeclipper
4 years ago

CohBar to list on Friday!
CohBar Announces Approval for Listing on the NASDAQ Capital Market
NASDAQ Trading to Begin on December 15, 2017 Under Existing Ticker Symbol CWBR
MENLO PARK, Calif., Dec. 13, 2017 (GLOBE NEWSWIRE) — CohBar, Inc. (OTCQX:CWBR) (TSXV:COB.U), an innovative biotechnology company focused on developing mitochondria based therapeutics (MBTs) to treat age-related diseases, today announced that The NASDAQ Stock Market LLC has approved the Company’s application to list its common stock on the NASDAQ Capital Market (NASDAQ).
CohBar’s common stock is expected to commence trading on the NASDAQ Capital Market at the opening of trading on December 15, 2017 under the ticker symbol CWBR. The Company’s common stock will continue to trade on the OTCQX until market close on December 14, 2017 under the ticker symbol CWBR. In addition to trading on the NASDAQ Capital Market, the Company’s common stock will also continue to trade on the TSX Venture Exchange under the ticker symbol COB.U.
β€œListing on NASDAQ represents a major milestone for our Company and its shareholders, reflecting the significant progress our team has made in preparing CB4211 for clinical trials, and in securing our leadership position in the development of MBTs, a new class of therapeutics with the potential to treat a wide range of age-related diseases,” said Simon Allen, CohBar CEO. β€œWe believe that our NASDAQ listing will significantly enhance our visibility in the marketplace, attract institutional investors, and ultimately help us to realize greater value for our shareholders as we expand our pipeline of novel therapeutics that harness the power of the mitochondria and its encoded peptides.”

Add a Topic
5916
Add a Topic
5971
Add a Topic
5971
πŸ‘ 16
fred
fred
4 years ago

Any insights on Capr which keeps plunging?

πŸ‘ 4
fred
fred
4 years ago

Any insight on Capr’s decline?

πŸ‘ 4
πŸ‘ 47658
fred
fred
4 years ago
Reply to  DrKSSMDPhD

Thank you. You still believe in this company?

πŸ‘ 4
πŸ‘ 47658
youronlyhope
youronlyhope
4 years ago

$RXII NP RXi Pharmaceuticals Announces Positive Results from Phase 2 Trial with RXI-109 for Dermal Scarring. “The exploratory endpoint for patient reported outcomes resulted in 88% of the patients indicating that RXI-109 treated scar looked better over control”

Shares down 1%. The financials dont look great and very little insider ownership however the market for a topical on scars would be pretty large even if it wouldn’t be covered by insurance. Anyone else see this as undervalued or at least worth the risk of a small position?

Add a Topic
882
πŸ‘ 85
πŸ‘ 11466
πŸ‘ 47658
youronlyhope
youronlyhope
4 years ago
Reply to  youronlyhope

SoGiAM/Dr. KSS I apologize I did do some searching and found posts from 2014 but missed the more blunt/direct remarks SOGiAM linked too. Ill be more diligent searching in the future. Thanks for the confirmation.

πŸ‘ 85
lanewalker
lanewalker
4 years ago

$HALO
Baker Bros Advisors Lp increased Halozyme Therapeutics Inc. (HALO) stake by 13.65% reported in 2017Q2 SEC filing. Baker Bros Advisors Lp acquired 189,917 shares as Halozyme Therapeutics Inc. (HALO)’s stock rose 2.38%. The Baker Bros Advisors Lp holds 1.58M shares with $20.27 million value, up from 1.39M last quarter. Halozyme Therapeutics Inc. now has $2.78 billion valuation. The stock decreased 0.05% or $0.01 during the last trading session, reaching $19.68. About 729,692 shares traded. Halozyme Therapeutics, Inc. (NASDAQ:HALO) has risen 44.89% since December 19, 2016 and is uptrending. It has outperformed by 28.19% the S&P500.

Add a Topic
5971
Add a Topic
5971
πŸ‘ 182
1 38 39 40